Healthtech, which has consistently been one of Southeast Asia’s top five most-funded sectors in recent quarters, seems to be losing momentum. Equity funding in the region’s healthtech startups in Q2 2024 was the lowest since at least Q1 2020.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
